Insmed (INSM) Tax Provisions (2010 - 2026)
Insmed (INSM) posted quarterly Tax Provisions of $1.5 million for Q1 2026, up 66.67% year-over-year from $900000.0 in Q1 2025, and little changed quarter-over-quarter from $1.5 million in Q4 2025.
Insmed (INSM) Tax Provisions (2010 - 2026) Analysis & Trends
Insmed's Tax Provisions history runs 16 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 66.67% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $5.5 million (up 37.85% YoY), while the FY2025 annual figure was $5.0 million, up 34.88% from the prior year.
- Tax Provisions for Q1 2026 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
- The five-year high for Tax Provisions was $1.5 million in Q4 2025, with the low at $125000.0 in Q4 2022.
- The 5-year median for Tax Provisions is $800000.0 (2024), against an average of $827235.3.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions decreased 16.5% in 2022, then soared 700.0% in 2023.
- Insmed's Tax Provisions stood at $125000.0 in 2022, then jumped by 700.0% to $1.0 million in 2023, then surged by 30.7% to $1.3 million in 2024, then climbed by 14.77% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
- Business Quant data shows INSM's Tax Provisions at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 544,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 483,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Jun 30, 2022 | 501,000.00 |
| Mar 31, 2022 | 385,000.00 |
| Dec 31, 2021 | -83,000.00 |
| Sep 30, 2021 | -2.58 Mn |